ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.738,98
-0,11%
Dow Jones
42.337,09
0,38%
Euro vs US Dollar
1,11614
-0,13%
Bitcoin
65.724,55
0,83%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Evogene Ltd (EVGN)

  7. Evogene Ltd (EVGN) News

EVGN

Evogene (EVGN)

Evogene Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EVGN
DatumZeitQuelleÜberschriftSymbolFirma
19/09/202422h15Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:EVGNEvogene Ltd
17/09/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
16/09/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
04/09/202413h00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:EVGNEvogene Ltd
26/08/202415h30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EVGNEvogene Ltd
23/08/202414h55PR Newswire (US)Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:EVGNEvogene Ltd
23/08/202414h50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
22/08/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
22/08/202413h00PR Newswire (US)Evogene Reports Second Quarter 2024 Financial ResultsNASDAQ:EVGNEvogene Ltd
12/08/202413h11PR Newswire (US)Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price RuleNASDAQ:EVGNEvogene Ltd
12/08/202413h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
12/08/202413h00PR Newswire (US)Evogene Schedules Second Quarter 2024 Financial Results ReleaseNASDAQ:EVGNEvogene Ltd
31/07/202413h00PR Newswire (US)Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in BrazilNASDAQ:EVGNEvogene Ltd
23/07/202414h48PR Newswire (US)Evogene Announces Expected Implementation of 1-for-10 Reverse Share SplitNASDAQ:EVGNEvogene Ltd
23/07/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
17/07/202414h00PR Newswire (US)ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-StimulantsNASDAQ:EVGNEvogene Ltd
02/07/202413h00PR Newswire (US)Lavie Bio Announces Commercial Expansion of Yalos™ to Winter WheatNASDAQ:EVGNEvogene Ltd
25/06/202413h00PR Newswire (US)Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African CountryNASDAQ:EVGNEvogene Ltd
17/06/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
06/06/202422h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
23/05/202417h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
23/05/202417h00PR Newswire (US)Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & MelanomaNASDAQ:EVGNEvogene Ltd
23/05/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
23/05/202413h00PR Newswire (US)Evogene Reports First Quarter 2024 Financial ResultsNASDAQ:EVGNEvogene Ltd
21/05/202413h03PR Newswire (US)Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor SeedsNASDAQ:EVGNEvogene Ltd
09/05/202413h00PR Newswire (US)Evogene Schedules First Quarter 2024 Financial Results ReleaseNASDAQ:EVGNEvogene Ltd
16/04/202413h00PR Newswire (US)Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual MeetingNASDAQ:EVGNEvogene Ltd
11/04/202413h00PR Newswire (US)Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual MeetingNASDAQ:EVGNEvogene Ltd
02/04/202413h00PR Newswire (US)Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food IndustryNASDAQ:EVGNEvogene Ltd
28/03/202414h00PR Newswire (US)Evogene Announces Filing of Annual Report on Form 20-FNASDAQ:EVGNEvogene Ltd
 Showing the most relevant articles for your search:NASDAQ:EVGN

Kürzlich von Ihnen besucht

TSXV
CTP.P
AMEX
IRTR
iShares Lifepath Retirem...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten